T
TNDM icon

Tidemark’s Tandem Diabetes Care TNDM Stock Holding History

Tidemark’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20
Closed -$848 – 681
2024
Q3 		$848 Hold
20
– – ﹤0.01% 580
2024
Q2 		$806 Hold
20
– – ﹤0.01% 575
2024
Q1 		$708 Hold
20
– – ﹤0.01% 655
2023
Q4 		$592 Buy
+20
New +$415 ﹤0.01% 655

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tidemark's TNDM Position: Q4 2024 in Review

Tidemark sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 20 shares — an estimated $848 sold.

Tidemark first reported a position in TNDM in Q4 2023 and held it in 4 quarters. The position peaked at $848 in Q3 2024. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • Tidemark reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • Tidemark sold 20 Tandem Diabetes Care shares in Q4 2024, an estimated $848.
  • Tidemark first reported a position in Tandem Diabetes Care in Q4 2023 and held it in 4 quarters.
  • Tidemark's Tandem Diabetes Care position peaked at $848 in Q3 2024.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on Tidemark's 13F filing for Q4 2024, filed 10 Feb 2025.